Study of Samalizumab in Patients With Advanced Cancer
Clinical trial NCT02987504 · TERMINATED
Trial details
- NCT number
- NCT02987504
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-17
- Primary completion
- 2017-09-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.